Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, June 18, 2013
Technology Networks
 
Register | Sign in
Home Page
  News
Return to the previous page

COLTHERES Consortium Identifies Molecular Signatures Leading to Personalized Therapies for Colorectal Patients

Published: Thursday, October 25, 2012
Last Updated: Wednesday, October 24, 2012
Bookmark and Share
18 month report also includes evidence to support novel therapeutic approaches.

Full access to this article is for registered users only.
Registration is free-of-charge and allows access to all content on our web communities.

Already registered? Then please log in at the top of the page.


Scientific News
DNA-Altering Enzyme is Essential for Blood Cell Development
The expression of specific genes is partially dictated by the way the DNA is packed into chromatin, a tightly packed combination of DNA and proteins known as histones.
DNA Sequencing Reveals Mucosal Melanoma's Bullseye
Scientists have found a molecular 'bullseye' for a rare form of melanoma, opening up opportunities for new targeted treatment.
Studies Illuminate Functions of RNA
Researchers at the University of California illuminate the functional importance of a relatively new class of RNA molecules.
Chemical Screen Points to New Line of Attack Against Neuroblastoma
In the war on neuroblastoma, the current chemical weaponry is reaching its limit.
Mouse Study Suggests Lead May Trigger Schizophrenia
Behavioral and MRI study in mice points to a synergistic relationship between lead exposure and schizophrenia gene.
Identified a Key Protein in Maintaining the Identity of B Lymphocytes
This finding could be useful for the study of blood diseases such as lymphoma and leukemia.
Gene Mutation Gives Boost to Brain Cancer Cells
An international team of researchers has found that a singular gene mutation helps brain cancer cells to not just survive, but grow tumors rapidly.
Potential New Way to Suppress Tumor Growth Discovered
The new mechanism opens up the possibility of developing a new class of anti-cancer drugs.
Enzyme-Activating Antibodies Revealed As Marker for Severe Rheumatoid Arthritis
Finding could lead to earlier diagnosis and new, more aggressive treatment for worst cases.
Imaging Biomarker Predicts Response to Rapid Antidepressant
A telltale boost of activity at the back of the brain while processing emotional information predicted depressed patients’ response to experimental antidepressant.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv
Go to ePosters.net